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including wnt1, wnt3a, wnt5a, wnt10b, b-catenin, sox9, runx2, osteo-
pontin, lipoprotein lipase, peroxisome proliferator-activated receptor
gamma (PPAR-g or PPARG), and collagen I, II, X mRNA on different
concentrations of TGF-b1 were detect by ELISA assay and ﬂuorescence
quantitative (FQ)-PCR, respectively.
Results: After cultured in the TGF-b1 medium for 14 days, BMSCs dif-
ferentiated into circular or polygonal cells. After 21 days, 95% of the cells
were circular or polygonal cells with blue secretory granules within the
cytoplasm by toluidine blue staining. Compared with the control group,
the content of GAG increased signiﬁcantly in the group of TGF-b1
medium, especially in 2ng/ml TGF-b1 group by ELISA method. FQ-PCR
results indicated that mRNA expression level of wnt1, wnt3a, wnt5a,
wnt10b and b-catenin after exposure to 2ng/ml TGF-b1 was obviously
suppressed compared with control group, and mRNA expression level
of sox9, collagen II was statistically enhanced, with an results of
inhibiting expression of runx2, osteopontin, lipoprotein lipase, PPAR-g,
and collagen I, X. Moreover, we found that the expression of chondro-
genic related genes was not upon a parallel line with the TGF-b1
concentration.
Conclusion: TGF-b1 can promote BMSCs differentiating into chon-
drocytes. During the differentiation progress, the expression of Wnt/b-
catenin signaling pathway related genes was inhibited and chon-
drocyte speciﬁc genes of sox9, collagen II mRNA were increased. TGF-b
may modulate chondrogenic differenciation though Wnt signaling
pathway.
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CELLS ISOLATED FROM FAT PAD AND SYNOVIAL FLUID. ARE THEY
SUITABLE FOR CARTILAGE REPAIR?
J.K. Garica, C. Mennan, J. Richardson, K. Wright, S. Roberts. Robert Jones
Agnes Hunt Hosp. (Keele Univ.), Oswestry, United Kingdom
Purpose: Autologous Chondrocyte Implantation (ACI) is used as a cel-
lular therapy for treating defects in articular cartilage. Successful ACI
depends on high cell number and quality of the cells which varies
between patients. Alternative cell sources within the joint may provide
a more preferable treatment for OA. The aim of this study is to evaluate
the clinical suitability of infrapatellar fat pad (FP) and synovial ﬂuid (SF)
cells for cartilage repair by determining their MSC-like proﬁle and
response to an inﬂammatory stimulus in vitro.
Methods: Fat pad and synovial ﬂuid were obtained with consent from
the knees of patients undergoing ACI treatment. Cells were isolated
from FP by enzymatic digestion with Collagenase I for 1 h at 37oC fol-
lowed by centrifugation. Synovial ﬂuid cells were obtained by cen-
trifuging the synovial ﬂuid. Resulting cell pellets were seeded onto
tissue culture plastic in DMEM-F12, 10 % FCS and Penicillin/Strepto-
mycin. Expression of cell surface markers was assessed using Flow
cytometry (FACSCanto II). The multipotency of these cells was tested by
culturing in monolayer in osteogenic and adipogenic media. Chondro-
genesis was assessed in 3D pellet culture for 21 days. To evaluate the
immunoresponsive nature of FP and SF cells, the expression of co-
stimulatory markers CD40, CD80, CD86, and Major Histocompatibility
complex II (HLA-DR) was tested before and after stimulation (48 h) with
low (25ng/ml) and high (500ng/ml) concentrations of interferon-g
(IFN-g). Results were compared to those obtained from bone marrow
derived mesenchymal stem cells (BMSCs).
Results: SF and FP cells showed the ability to differentiate down
osteogenic, adipogenic and chondrogenic lineages as shown by positive
alkaline phosphatase (bone), Oil Red O (lipid) and Toluidine blue (gly-
cosaminoglycan) staining.
Cells from both SF and FP were positive for the MSC markers CD73,
CD90, CD105 and negative for HLA-DR. Following stimulation with IFN-
g, both SF and FP cells upregulated CD40 and HLA-DR. In comparison,
BMSCs upregulated HLA-DR after IFN- g stimulation but not the co-
stimulatory marker CD40.
Conclusion: Cells isolated from FP and SF of osteoarthritic joints display
immunogenic properties after stimulation with the pro-inﬂammatory
cytokine IFN-g which may make them unsuitable as alternative cell
sources for ACI. Despite the production of co-stimulatory markers
(CD40) and up regulation of HLA-DR as mentioned above, these cells do
show multipotency via their ability to differentiate down osteogenic,
adipogenic and chondrogenic lineages and they express the MSC
markers CD73, 90 and 105. Their immunoresponsive nature needs to bestudied further before these cells could be considered for routine
applications for cartilage repair.
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DOES MACROPHAGE DEPLETION & CYTOKINE STIMULATION AFFECT
THE PHENOTYPE OF SYNOVIAL MESENCHYMAL PROGENITOR CELLS
IN VITRO?
A. Fichadiya, C. Frank, R. Yates, R. Krawetz. Univ. of Calgary, Calgary, AB,
Canada
Purpose: The aim of the present study was to elucidate the relationship
between synovial mesenchymal progenitor cells (sMPCs) and macro-
phages of the knee joint in OA pathogenesis. Speciﬁcally, this study
sought to assess how components of the macrophage secretome (pro-
and anti-inﬂammatory activation and polarization factors) affect the
chondrogenic capacity of sMPCs in vitro. In addition to this, the effects
of macrophage depletion from OA and normal biopsied human syno-
vium were also assessed.
Methods: Patients with clinical and radiographic OA with no other co-
morbidities consented and had synovial membrane biopsies obtained
during knee arthroplasty or meniscal/ligamentous repair at the Peter
Lougheed Centre, Canada. Synovial ﬂuid and synovial membrane
biopsies from macroscopically normal knees were obtained from
cadavers less the 4 hrs after death. Tissue donors were received by the
Southern Alberta Organ and Tissue Donation Program (SAOTDP). OA
and normal biopsy samples were freshly plated and received 40ng/ml
of IFN-g, TNFa, Il-4, or IL-10, with or without Dichlor-
omethylenediphosphonic acid disodium salt (Clodronate Disodium -
Sigma) in solution every 4 days for 12 days post seeding (clodronate
disodium is a ﬁrst generation bisphosphonate utilized in research for
the depletion of macrophages). Samples of the supernatant are also
collected on days 4, 8, and 12 for proteomic assessment via Luminex.
Following this treated 12 day outgrowth of sMPCs, cells are isolated,
puriﬁed, expanded, and placed in 3 week chondrogenic differentiation
(in pellet culture aggregates). qRT-PCR is conducted thereafter to assess
gene expression levels of chondrogenic factors in addition to qualitative
alcian blue staining.
Results: Our study revealed greater expression levels of Sox9, Col2a and
Aggrecan on sMPCs which came from OA biopsy specimens that
received the clodronate-only treatment in comparison to untreated
biopsy specimens following chondrogenic differentiation. OA Biopsies
which received anti-inﬂammatory cytokines (IL-10 & IL-4) during sMPC
outgrowth also showed greater expression levels of Sox9, Col2a and
Aggrecan following chondrogenic differentiation in comparison to
those receiving pro-inﬂammatory cytokines (IFN-g & TNFa). Addition-
ally, OA biopsies receiving either pro-or anti-inﬂammatory cytokines
alongside clodronate showed variable sMPC expression levels of
chondrogenic factors following differentiation. The TNFa þ Clodronate
group showed the most reduced expression levels in comparison to
sMPCs from untreated biopsies. Normal biopsies which underwent the
same treatment regimens demonstrated similar results in the way of
reduced chondrogenic gene expression following pro-inﬂammatory
exposure, and increased expression following clodronate treatment.
Conclusions: Our ﬁndings shed light on macrophage effects on sMPC
phenotype. Our results demonstrate that depletion of synovial macro-
phages increases the chondrogenic capacity of sMPCs and that pro-
inﬂammatory cytokines which constitute anM1macrophage secretome
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raise interesting insight into the inﬂammatory inﬂuences on OA
pathogenesis and cartilage regeneration.
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MESENCHYMAL STEM CELLS IN SYNOVIAL FLUID INCREASE AFTER
SYNOVIAL BIOPSY
M. Ojima y, I. Sekiya z, K. Tsuji x, T. Muneta y. y Joint Surgery and Sports
Med., Tokyo Med. and Dental Univ., Tokyo, Japan; zCtr. for Stem Cell and
Regenerative Med., Tokyo Med. and Dental Univ., Tokyo, Japan; xDept. of
Cartilage Regeneration, Tokyo Med. and Dental Univ., Tokyo, Japan
Purpose: We previously reported that the number of mesenchymal
stem cells (MSCs) in synovial ﬂuid was higher in knees with anterior
cruciate ligament insufﬁciency and osteoarthritis than in normal knees.
MSCs in synovial ﬂuid were similar to synovium MSCs from the view-
point of morphological and gene proﬁles. In this study, we investigated
whether the number of MSCs in synovial ﬂuid increased after synovial
biopsy.
Methods: The studywas approved by an institutional review board, and
informed consents were obtained from all study subjects. We obtained
synovial ﬂuid from the knee joints of 9 patients, who underwent
transplantation of synovial MSCs for cartilage injury, before and 2
weeks after harvest of 0.5g of synovium. We expanded the nucleated
cells in synovial ﬂuid for 2 weeks and counted the number of cell col-
onies stained with crystal violet. We also examined chon-
drogenic,adipogenic and osteogenic differentiation of these cells. For
gene proﬁle,28,000 genes were analyzed with microarray, and gene
expressions were conﬁrmed with quantitative real time-PCR.
Results: The total cell number obtained from 1ml of synovial ﬂuid
before synovial biopsy was 142  192 and that 2 weeks after synovial
biopsy was 238  196. Total cell number obtained from 1ml of synovial
ﬂuid before synovial biopsy was (95129) 103 and that 2 weeks after
synovial biopsy was (241  258) 103.Both the number of cell colonies
and the number of cells signiﬁcantly increased after synovial biopsy (p
< 0.05). The colony forming cells differentiated into chondrocytes,adipocytes, and osteoblasts. The expressions of subset of genes altered
in MSCs derived from synovial ﬂuid obtained before and after synovial
biopsy.
Conclusion:MSCs in synovial ﬂuid increased in the knee after synovial
biopsy.
This was possibly due to inﬂammation and the repair process after
synovial biopsy. It would be an interesting future topic to examine how
many MSCs in synovial ﬂuid contributed to the repair of the synovium.
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EXPRESSION ANALYSIS OF OSTEOARTHRITIS ASSOCIATED GENES IN
MESENCHYMAL STEM CELLS DIFFERENTIATING INTO JOINT-
ASSOCIATED CELLS
E.L. Rogers, L.N. Reynard, K. Rennie, K. Rankin, J. Loughlin. Newcastle
Univ., Newcastle upon Tyne, United Kingdom
Purpose: Historically recognised as a primary cartilage pathology,
osteoarthritis (OA) is now understood to affect all joint-associated tis-
sues. It has been hypothesised that gene dysregulation during joint
formation may lead to the abnormal development and maintenance, or
repair, of joint-associated tissues, thus conferring OA susceptibility.
Genome wide association studies (GWAS) have identiﬁed multiple OA-
associated genes, some of which have been shown to function during
cell development and differentiation. However, many genes identiﬁed
by such studies remain to be characterised. The ﬁrst aim of this study
was therefore to establish if a panel of OA-associated genes are
expressed in mesenchymal stem cells (MSCs) that have undergone
directed differentiation into joint-associated cells, and whether differ-
ential expression occurs in MSCs from OA patients. Additionally, this
study sought to analyse the differentiation potential of OA patient-
derived MSCs compared to MSCs from controls.
Methods: MSCs were extracted from the femoral head and from bone
marrow aspirates of OA patients undergoing hip or knee arthroplasty
respectively. Control MSCs were obtained from both neck of femur
(NOF) fracture patients and young, healthy individuals. MSCs were
subsequently differentiated using transwell culturing into osteoblasts,
chondrocytes and adipocytes over a 14 day period, and RNA was
extracted from cells harvested on days 0, 3 and 14 of differentiation. The
differentiation potential of MSCs was analysed by histological staining
and by quantitative PCR (qPCR) of lineage-speciﬁc genes. A selection of
13 genes within OA-susceptibility loci, as identiﬁed by GWAS, were
studied during differentiation by qPCR.
Results: Osteogenic potential was preserved in OA patient-derived MSCs
when compared to controls, as determined by Fast blue RR alkaline
phosphatase staining and qPCR of osteogenic marker genes. Adipogenic
differentiation, assessedby PPARg induction,was found to be less efﬁcient
inOApatientMSCs,withdecreased inductionof PPARgwhencompared to
controls. qPCRof cDNA from chondrogenesis experiments revealed a large
degree of inter-individual variability when analysing chondrogenic-spe-
ciﬁc genes, meaning it was not possible to deduce the chondrogenic efﬁ-
ciency in OA patient MSCs compared to controls. Of the genes contained
within OA-associated regions, MCF2L was the only gene for which
expression was not detected in any lineage during differentiation. The
remaining 12 genes were expressed in a dynamic manner, with a large
degree of inter-individual variability. Differential expression of individual
genes was not apparent when comparing the OA and control groups.
Conclusions: Differentiation potential of OA-derived MSCs could be
impaired during chondrogenesis and adipogenesis, while osteogenic
differentiation appears to be preserved. To date, there are few published
reports on the efﬁciency of OA-MSC chondrogenesis using transwell
culture, which is believed to be a more faithful recapitulation of
chondrogenesis when compared to other techniques. This may there-
fore have bearings on the success of autologous stem cell treatments for
osteoarthritic patients, with further studies utilising more samples
required to uphold this ﬁnding. MCF2L is not expressed in MSCs during
in vitro differentiation into joint associated cells, which would suggest
any potential effects of this gene on the OA joint is asserted later in
development, or in the mature joint. All other genes within the OA-
associated regions were expressed in a variety of patterns, indicating a
possible function in joint development. However, no speciﬁc difference
in expression was noted when comparing OA and control gene
expression, meaning it was not possible to deduce speciﬁc genes of
interest for future study. Despite this, the dynamic of expression of OA-
associated genes in differentiating MSCs supports the possibility of a
developmental aetiology of OA.
